BIOANALYTICAL SYSTEMS,
INC.
|
(Exact
name of registrant as specified in its
charter)
|
Indiana
|
0-23357
|
35-1345024
|
||
(State or other
jurisdiction of
incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification
No.)
|
2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
|
47906-1382
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange
Act(17CFR240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
|
(d)
|
Exhibits
|
|
10.1
|
|
Fourth
Amendment to Loan Agreement between Bioanalytical Systems, Inc. and
Regions Bank, as amended on December 29,
2010.
|
BIOANALYTICAL
SYSTEMS, INC.
|
||
Date:
January 5, 2011
|
By:
|
/s/ Michael R. Cox
|
Michael R. Cox
|
||
VP-Finance and
Administration
|
Exhibit No.
|
Description
|
|
10.1
|
Fourth
Amendment to Loan Agreement between Bioanalytical Systems, Inc. and
Regions Bank, as amended on December 29,
2010.
|